Ad copy

I've treated chronic eczema in Germany for 18 years without indefinite steroid creams. When I moved to America, I couldn't believe what dermatologists here were telling their patients. I've been a dermatologist for 20 years. The first 18, I practiced in Munich. I moved to the United States two years ago when my husband's company transferred him to Boston. I joined a dermatology practice here. Good practice. Good doctors. And in my first three months, I saw something that kept me up at night. Women in their 40s, 50s, and 60s coming in with patches across their arms, behind their knees, on their hands, on their faces. Red. Cracked. Weeping. Skin lifting in flakes. Every one of them said the same thing. "My dermatologist has been managing it for years." Managing it. In Germany, we don't manage chronic eczema progression while prescribing topical steroids that can't reach the source. We address the gut. Because by the time the flares have spread to multiple body sites, something has already failed — structurally, systemically — and applying corticosteroid to inflamed skin won't fix that. It only manages what's already spreading. Here's what your dermatologist probably hasn't told you about what chronic eczema actually is. Your skin is not where eczema lives. It's where eczema ends. The actual fire is two feet south of your skin. In your gut. When you apply a topical steroid, it suppresses the inflammation at the surface. Less than 3% of what's driving the flare is actually being addressed. 97% sits underneath — in your gut — pumping inflammatory cytokines into your bloodstream around the clock. But that's only the first barrier. The bacterial overgrowth in your small intestine has built a biofilm — a protective biological fortress — that makes the overgrowth up to 1,000 times more resistant to whatever your immune system or antibiotics try to throw at it. Two barriers. The skin barrier on top. A gut biofilm fortress underneath, two feet south. No amount of cream dissolves that gut biofilm. Topical steroids suppress surface-level inflammation on exposed skin — that's what they do. They were never designed to reach a bacterial overgrowth hiding in the small intestine and dissolve a biofilm shield around it. So the inflammation keeps generating. The overgrowth keeps producing LPS. Adjacent body sites get colonized by inflammation. And your dermatologist keeps prescribing stronger steroids and telling you to be patient. Peer-reviewed dermatology and gut-skin axis research has documented for years that biofilm-protected gut overgrowth — not treatment strength — is what drives chronic eczema persistence in patients with otherwise consistent compliance. Not poor moisturizing. Not inconsistency. Biofilm-protected gut dysbiosis driving systemic inflammation. Your compliance isn't the problem. The protocol treating compliance as the solution is. I want to be honest about Dupixent. Because most of my Boston patients had been told Dupixent was their next step. Some had already done it. Some had done it twice. Dupixent enters the bloodstream — which is the correct delivery route. It bypasses the broken skin barrier. It blocks the IL-4 and IL-13 cytokines from reaching skin tissue. What it can't do is shut off the gut overgrowth that's producing those cytokines in the first place. Dupixent partially blocks the inflammatory signal once it's already firing. When the patient stops the injections — because of cost, side effects, or insurance — the gut overgrowth is still intact. The biofilm is still there. The cytokines start flooding the bloodstream again. 25-50% of patients experience meaningful flare return within twelve months of stopping. Dupixent is like draining a flooded basement while the pipe is still leaking. The water goes down. For a while. I've seen it in patients who came to me after Dupixent. Good initial response. Maybe a year of clearer skin. And 8 months after stopping, the patches creeping back on the inner elbows. Because nothing had permanently shut off the gut driver. This is what nobody tells you about where untreated gut dysbiosis leads. It doesn't stay behind one patch. The overgrowth produces more inflammatory triggers. Those triggers travel through the bloodstream to adjacent skin sites. Each new patch becomes a new visible endpoint of the same body-wide inflammatory event. One flare on the inner elbow at month three can become four patches by year one. Patches across the arms by year three. Full-body flares by year six. I've had the conversation that follows more times than I should have. With women who did everything their dermatologist told them. Who moisturized every day for years. Who never missed a single application. Who still, over time, watched the eczema spread to every part of their body they used to be able to show. The cream addressed the surface. The gut underneath kept advancing. Silently, systematically — until the damage wasn't patchable with topicals anymore and the only options left were biologic injections or full-body phototherapy. When I arrived in the US, I assumed the research on systemic gut-skin axis intervention simply hadn't made it here yet. In Germany, we'd been working with lipid-soluble gut biofilm dissolution protocols for over a decade. It emerged from European dermatology research in the early 2010s — dermatologists and gastroenterologists studying why some patients responded to Dupixent and others didn't, despite identical treatment protocols. What they found was that non-responders had significantly more entrenched gut biofilms and more severe small-intestinal bacterial overgrowth. The Dupixent couldn't shut off the cytokine production at the source — only block the signal once it had already been fired. It wasn't drug failure. It was source failure. That research led to trials on whether dissolving the gut biofilm with lipid-soluble compounds — specifically carvacrol from oregano oil — could clear chronic eczema without indefinite Dupixent. In cases where the gut biofilm was the primary barrier, not immune resistance. Published research documented direct biofilm matrix degradation with carvacrol at 70%+ concentration. The oily gut biofilm shield is dissolved by the oily compound — like dissolves like. Delivered orally. Past stomach acid in oil-based softgel form. To the small intestine, where the overgrowth actually lives. A 2014 study found carvacrol outperformed prescription rifaximin for clearing small-intestinal bacterial overgrowth — 46% efficacy versus 34%. Combined with thymoquinone from black seed oil — which directly suppresses the IL-2, IL-6, and IL-1β cytokines traveling from gut to skin, while supporting tight junction repair in the gut lining — the protocol dissolves the fortress AND quiets the inflammation already in circulation. No injection cycles. No 12-month forced biologic dependency. Continuous oral delivery until the loop is fully broken. I want to tell you about one patient. Because her results are what I see when people finally address the right organ. She was 56. Had been on topical protocols since 50. Seven patches across both arms and behind both knees. Her previous dermatologist had recommended Dupixent. She came to me for a second opinion. Her compliance was perfect. The eczema was real. The gut was the source. In Germany, before we ever reach for Dupixent, we ask one question: have we addressed the gut? Dupixent partially blocks the cytokine signal. It doesn't shut off the source. I recommended 90 days of systemic gut biofilm dissolution before making any Dupixent decisions. She was skeptical. Six years of perfect compliance hadn't produced one week of stable skin. She didn't believe capsules could change what six years of creams hadn't. I explained it simply. Steroid cream sits on inflamed skin. That's what it does. It does not dissolve gut biofilm. Your skin isn't getting worse because the cream is weak. It's getting worse because the gut overgrowth is intact and the treatment can't reach the source two feet south of where you're applying it. You can paint a vault perfectly. If the lock is still closed, nothing gets in. She agreed to try. Orgatics Oregano & Black Seed Oil. Pharmaceutical-grade. 70%+ standardized carvacrol. Cold-pressed thymoquinone. Two capsules with breakfast. Week 1: Inflammation calmer across all seven patches. The angry redness she'd carried for years — visibly reduced. Week 2: A thin band of smooth, soft skin returning at the edges of the largest patches. The first stable skin in six years. Week 4: Smooth bands on five patches. The cracking had stopped. The redness being pushed inward by healthy skin. Week 8: Over 80% reduction in patch surface area. The cracking stopped on all sites. No new flares. Week 12: Her dermatologist — her previous one, the one who recommended Dupixent — examined her skin. Then examined again. "The barrier recovery is complete. Healthy thickness. No active inflammation." She didn't need Dupixent. She didn't need phototherapy. In Germany, this is where we start. Not with biologic injections. With the source. I share this because I spent two years quietly frustrated by what I see here. Women who came to me after years of being told to keep moisturizing — while their eczema silently spread from patch to patch. Women who felt like they were failing. Like their bodies were betraying them despite perfect compliance. They weren't failing. The protocol was failing them. American dermatology training focuses on topical steroid protocols and Dupixent escalation. Systemic gut-skin axis intervention — addressing the actual source — isn't part of standard training. Most American dermatologists graduated before this research was emphasized. They practice what they were taught. That's not a criticism. It's just where the knowledge gap sits. But the research exists. And you don't have to wait for your dermatologist to find it. If you've been moisturizing for months or years with no stable skin — if you've done Dupixent and watched it come back — if you've been told your eczema is "treatment-resistant" but your compliance has been perfect — The answer isn't to apply more consistently. It's to dissolve the barrier your treatment was never designed to reach. I'll leave a link below to the product I recommend to my own patients. I have no financial relationship with this company. I recommend it because the mechanism is sound, the research supports it, and I've seen it work. You've spent years doing what you were told. It's time to address what you were never told. 90-day money-back guarantee. Two capsules with breakfast. No nightly ritual. Your skin isn't failing you. The protocol treating your compliance as the problem is what's failing you. The gut biofilm is the barrier. Dissolve it.